These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 27619)
1. Mannitol and delayed hypersensitivity in the rat. Tarayre JP; Vilain P; Lauressergues H J Pharm Pharmacol; 1978 Jul; 30(7):458-9. PubMed ID: 27619 [No Abstract] [Full Text] [Related]
2. Action of mannitol in various immunological experimental models. Tarayre JP; Vilain P; Lauressergues H Agents Actions; 1979 Oct; 9(4):369-74. PubMed ID: 229721 [TBL] [Abstract][Full Text] [Related]
3. The influence of various methods of sensitization on delayed hypersensitivity to Bordetella pertussis in the Sprague Dawley Rat. Tarayre JP; Delhon A; Lauressergues H Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):162-70. PubMed ID: 200190 [TBL] [Abstract][Full Text] [Related]
4. Action of phenylbutazone, cyclophosphamide and prednacinolone on pleurisy due to Bordetella pertussis hypersensitivity in the rat. Tarayre JP; Lauressergues H Arch Int Pharmacodyn Ther; 1978 Sep; 235(1):165-9. PubMed ID: 216327 [TBL] [Abstract][Full Text] [Related]
5. Action of chloroquine on pleurisy due to Bordetella pertussis hypersensitivity. Tarayre JP; Lauressergues H J Pharm Pharmacol; 1978 Sep; 30(9):599-600. PubMed ID: 29110 [No Abstract] [Full Text] [Related]
6. Action of various drugs with anti-inflammatory or anti-rheumatic properties on pleurisy due to Bordetella pertussis hypersensitivity in the rat. Tarayre JP; Delhon A; Lauressergues H Pharmacology; 1979; 19(6):323-9. PubMed ID: 232922 [TBL] [Abstract][Full Text] [Related]
7. Topical mannitol reduces inflammatory edema in a rat model of arthritis. Cavone L; Calosi L; Cinci L; Moroni F; Chiarugi A Pharmacology; 2012; 89(1-2):18-21. PubMed ID: 22236612 [TBL] [Abstract][Full Text] [Related]
8. The anti-allergic inflammation action of Saikosaponins. Zhou ZC; Wang GZ; Ma JL J Tradit Chin Med; 1983 Jun; 3(2):103-12. PubMed ID: 6225915 [No Abstract] [Full Text] [Related]
9. Novel disease-modifying antirheumatic drugs. I. Synthesis and antiarthritic activity of 2-(4-methylphenyl)benzothiazoles. Hori N; Tsukamoto G; Imamura A; Ohashi M; Saito T; Yoshino K Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2387-90. PubMed ID: 1446360 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the effect of phenylbutazone, desonide and cyclophosphamide on four types of experimental pleurisy. Tarayre JP; Lauressergues H J Pharm Pharmacol; 1980 Jun; 32(6):408-12. PubMed ID: 6106673 [TBL] [Abstract][Full Text] [Related]
11. THE MECHANISM OF ANAPHYLAXIS. II. THE ROLE OF 'MAST CELL SENSITIZING' ANTIBODY AND DELAYED HYPERSENSITIVITY IN RAT ANAPHYLAXIS. MOTA I Immunology; 1964 Nov; 7(6):700-6. PubMed ID: 14239844 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological profile of 4-(2',4'-difluorobiphenyl-4-yl)-2-methylbutyric acid (deoxoflobufen). Bulej P; Kuchar M; Panajotova V; Jegorov A Arzneimittelforschung; 2005; 55(8):466-72. PubMed ID: 16149715 [TBL] [Abstract][Full Text] [Related]
13. Treatment with anti-C5aR mAb leads to early-onset clinical and mechanistic effects in the murine delayed-type hypersensitivity arthritis model. Atkinson SM; Nansen A; Usher PA; Sondergaard BC; Mackay CR; Friedrichsen B; Chang CC; Tang R; Skov S; Haase C; Hornum L Autoimmunity; 2015; 48(7):460-70. PubMed ID: 25915570 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and antiinflammatory activity of hexahydrothiopyrano[4,3-c]pyrazoles and related analogues. Rovnyak GC; Millonig RC; Schwartz J; Shu V J Med Chem; 1982 Dec; 25(12):1482-8. PubMed ID: 6218302 [TBL] [Abstract][Full Text] [Related]
15. Studies on anti-inflammatory agents. VI. Synthesis and pharmacological properties of 2,3-diarylthiophenes. Tsuji K; Nakamura K; Ogino T; Konishi N; Tojo T; Ochi T; Seki N; Matsuo M Chem Pharm Bull (Tokyo); 1998 Feb; 46(2):279-86. PubMed ID: 9501462 [TBL] [Abstract][Full Text] [Related]
16. Demonstration of novel anti-arthritic and anti-inflammatory effects of diphosphonates. Dunn CJ; Galinet LA; Wu H; Nugent RA; Schlachter ST; Staite ND; Aspar DG; Elliott GA; Essani NA; Rohloff NA J Pharmacol Exp Ther; 1993 Sep; 266(3):1691-8. PubMed ID: 8371167 [TBL] [Abstract][Full Text] [Related]
17. Delayed type hypersensitivity induced by LPF from Bordetella pertussis. Guadalupe Cortés JM; Juliano Y; Mendes NF; Mendes E Allergol Immunopathol (Madr); 1986; 14(4):311-7. PubMed ID: 2877558 [TBL] [Abstract][Full Text] [Related]
18. Suppression of adjuvant arthritis in rats by oral administration of type II collagen in combination with type I interferon. Yoshino S J Pharm Pharmacol; 1996 Jul; 48(7):702-5. PubMed ID: 8866333 [TBL] [Abstract][Full Text] [Related]
19. Effect of FK 506 (FR 900506) on collagen arthritis in rats: a preliminary report. Arita C; Hotokebuchi T; Miyahara H; Arai K; Sugioka Y; Takagishi K; Kaibara N Transplant Proc; 1989 Feb; 21(1 Pt 1):1056-8. PubMed ID: 2468206 [No Abstract] [Full Text] [Related]
20. [Anti-inflammatory effect of aconitines]. Shi H; Zhou C; Li Y; Wang G; Sun Y Zhongguo Zhong Yao Za Zhi; 1990 Mar; 15(3):174-7, 192. PubMed ID: 2150749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]